Jump to content

Alprenoxime

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 184.60.31.237 (talk) at 02:58, 13 April 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Alprenoxime
Clinical data
ATC code
  • None
Identifiers
  • 1-(2-allylphenoxy)-3-(isopropylamino)propan-2-one oxime
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC15H22N2O2
Molar mass262.35 g/mol g·mol−1
3D model (JSmol)
  • O(c1ccccc1C\C=C)C\C(=N\O)CNC(C)C
  • InChI=1S/C15H22N2O2/c1-4-7-13-8-5-6-9-15(13)19-11-14(17-18)10-16-12(2)3/h4-6,8-9,12,16,18H,1,7,10-11H2,2-3H3/b17-14+ checkY
  • Key:XFQFSSGNEFUEPA-SAPNQHFASA-N checkY
  (verify)

Alprenoxime is a beta blocker.[1] It is a prodrug to alprenolol.[1]

Defined Bond Stereocenter Count 1
Molecular Weight 262.34738 g/mol
Molecular Formula C15H22N2O2
XLogP3 3.4
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 8
Exact Mass 262.168128 g/mol
Monoisotopic Mass 262.168128 g/mol
Topological Polar Surface Area 53.8 A^2
Heavy Atom Count 19
Formal Charge 0
Complexity 290
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1

References

Template:Research help

  1. ^ a b Prokai L, Wu WM, Somogyi G, Bodor N (May 1995). "Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue". Journal of Medicinal Chemistry. 38 (11): 2018–20. doi:10.1021/jm00011a021. PMID 7783133.{{cite journal}}: CS1 maint: multiple names: authors list (link)